drugset / Trial / NCT00133757
Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
Phase 1
Completed
50 enrolled
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupDouble-blind
Summary
In this study we, the investigators at the Centre for Addiction and Mental Health, intend to explore whether bupropion is able to reduce smokers' responses to cigarette-related environmental cues, and craving. Previous studies have indicated that bupropion may be able to achieve these outcomes. Therefore, we predict that smokers treated with bupropion for several weeks will show reduced reactivity to cigarette cues and craving.
Timeline
- Start
- 2005-06
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 150 mg | Oral |